ロード中...
Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
Collecting duct carcinoma (CDC) is a rare, extremely aggressive form of renal cancer. Recently, immune checkpoint inhibitors (ICI), anti-programmed death-1 (PD-1) antibody, and anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) antibody were approved for use against metastatic renal cell carc...
保存先:
| 出版年: | Case Rep Urol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8270715/ https://ncbi.nlm.nih.gov/pubmed/34306793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9936330 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|